✦ LIBER ✦

The combined modality therapy of diffuse histology non-hodgkin lymphoma with combination chemotherapy and total body irradiation

✍ Scribed by James K. Weick; Antonio R. Antunez; Carol J. Fabian

Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 100 KB
Volume: 7
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(81)90649-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combined modality therapy of diffuse

The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation

✍ James K. Weick; A. Antunez; Thomas A. Kraus; Carol J. Fabian; D. Dixon 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 350 KB

A comparison between combination chemoth

A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma

✍ Harmar D. Brereton; Robert C. Young; Dan L. Longo; Leland R. Kirkland; Costan W. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 2 views

Salvage chemotherapy for non Hodgkin's l

Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of ccnu and vinblastine

✍ Dr. G. Palmieri; R. Lauria; F. Caponigro; C. Pagliarulo; V. Montesarchio; F. Nuz 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Twenty patients with relapsed or refractory, intermediate or high grade non Hodgkin's lymphoma were treated with a combination of CCNU and vinblastine. Complete responses occurred in four patients (20 per cent), partial responses in eight (40 per cent), for an overall response rate of 60 per cent. T

The treatment of stage III – IV non-Hodg

The treatment of stage III – IV non-Hodgkin'S lymphoma of “favorable” histologic type. A randomized comparison of whole body irradiation, combination chemotherapy, and single agent chemotherapy

✍ Richard T. Hoppe; Saul A. Rosenberg; Henry S. Kaplan 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A radiotherapeutic experience for non-ho

A radiotherapeutic experience for non-hodgkin's lymphoma: the prognostic importance of histological grade and the role of combined chemotherapy

✍ Kazushige Tsutsui; Yuta Shibamoto; Hirohiko Yamabe; Mitsuyuki Abe 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Management of stage I–II diffuse aggress

Management of stage I–II diffuse aggressive non-hodgkin's lymphoma of the waldeyer's ring: Combined modality therapy versus radiotherapy alone

✍ R. Liang; R. P. Ng; D. Todd; D. Choy; R. K. K. Khoo; F. C. S. Ho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

Twenty five patients with stage I and I1 diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring were reviewed. There were 19 patients with diffuse histiocytic, 4 diffuse lymphocytic poorly differentiated and 2 diffuse mixed lymphoma. Their median age was 51 years. There were 12 males and 1